Trials / Terminated
TerminatedNCT00083434
Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effectiveness of epoetin alfa in treating anemia in patients who have cancer or who no longer have any signs of the cancer, but remain anemic as a result of their treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epoetin alfa |
Timeline
- Start date
- 2004-02-01
- Completion
- 2004-10-01
- First posted
- 2004-05-26
- Last updated
- 2011-04-27
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00083434. Inclusion in this directory is not an endorsement.